BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantQC
Quadrille Capital
Activity from announced rounds
Activity in this selectionscott-adelson-137d8262
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $165M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionAdonis
Provides AI-driven revenue cycle operations for healthcare providers
$40MSeries C
Role not disclosedGitGuardian
Provides a non-human identity security platform to detect and remediate leaked secrets in code
$50MSeries C
Role not disclosed